ACTSI Investigator Dr. Mark Mulligan in the News
Mark J. Mulligan, MD, FIDSA
Dr. Mulligan is an ACTSI investigator, professor in the Division of Infectious Diseases and trained as a molecular virologist with Richard Compans at UAB. He leads a group of collaborating faculty and staff at the Hope Clinic of the Emory Vaccine Center. His research focuses on understanding the mechanisms of successful vaccines and developing needed new or improved vaccines, e.g., HIV, pandemic influenza, tuberculosis and biodefense vaccines.
The GA Voice | Get ready to ride for HIV research
November 3, 2011
Georgia Health News | Enlist in the war against HIV
May 18, 2012
Emory News Center | Need for HIV vaccine is greater than ever
May 18, 2012